First Time Loading...

Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 173.79 USD 0.03%
Updated: May 17, 2024

Zoetis Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zoetis Inc
Income from Continuing Operations Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Zoetis Inc
NYSE:ZTS
Income from Continuing Operations
$2.4B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
17%
Johnson & Johnson
NYSE:JNJ
Income from Continuing Operations
$17.1B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Income from Continuing Operations
-$6.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Income from Continuing Operations
-$254m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Income from Continuing Operations
$2.3B
CAGR 3-Years
-22%
CAGR 5-Years
-23%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Income from Continuing Operations
$6.1B
CAGR 3-Years
0%
CAGR 5-Years
18%
CAGR 10-Years
5%

See Also

What is Zoetis Inc's Income from Continuing Operations?
Income from Continuing Operations
2.4B USD

Based on the financial report for Mar 31, 2024, Zoetis Inc's Income from Continuing Operations amounts to 2.4B USD.

What is Zoetis Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
17%

Over the last year, the Income from Continuing Operations growth was 15%. The average annual Income from Continuing Operations growth rates for Zoetis Inc have been 10% over the past three years , 12% over the past five years , and 17% over the past ten years .